Peripheral B cell tolerance differs from central tolerance in anatomic location, in the stage of B cell development, and in the diversity of Ag-responsive cells. B cells in secondary lymphoid organs are heterogeneous, including numerous subtypes such as B-1, marginal zone, transitional, and follicular B cells, which likely respond differently from one another to ligand encounter. We showed recently that central B cell tolerance mediated by receptor editing was induced in mice carrying high levels of a ubiquitously expressed -macroself Ag, a synthetic superantigen reactive to Ig. In this study, we characterize a new transgenic line that has a distinctly lower expression pattern from those described previously; the B cell tolerance phenotype of these mice is characterized by the presence of significant numbers of immature ؉ B cells in the spleen, the loss of mature follicular and marginal zone B cells, the persistence of ؉ B-1 cells in the peritoneal cavity, and significant levels of serum IgM,. These findings suggest distinct signaling thresholds for tolerance among peripheral B cell subsets reactive with an identical ligand.
A lthough it has been established for many years that B cell tolerance is an active process (1), the parameters that permit persistence of autoreactive cells and eventual Ab secretion when tolerance is broken are poorly understood. At early stages of B cell development, tolerance mechanisms include developmental arrest, receptor editing, and apoptosis of cells that fail to effectively edit (2) . In contrast, Ags that are unavailable in the bone marrow or that have low valence or affinity to the BCR fail to induce central tolerance; instead such Ags may promote tolerance in the periphery by the induction of anergy and clonal elimination in cells at a later developmental stage (3) (4) (5) (6) .
Analysis of tolerance in peripheral B cells is complicated because of the heterogeneity of these cells. Major subsets include newly formed "transitional" B cells, follicular B cells, marginal zone (MZ) 3 B cells, B-1 cells, and memory B cells. Transitional B cells include the immediate bone marrow emigrants, T-1 cells, and their developmental successors, T-2 cells (7, 8) . Most transitional B cells turn over rapidly, but some are recruited into a long-lived pool that includes follicular B cells, splenic MZ B cells, and other subtypes. B-1 cells, which are mainly, but not exclusively, derived from fetal proB cells, preferentially populate the peritoneal cavity and lamina propria and are found in low numbers in other lymphoid tissues (9, 10) . It is believed that B-1 and MZ B cells have self-renewal capacity, whereas follicular B cells, although longlived, must be replenished from sIg Ϫ bone marrow progenitors (11, 12) .
B cell subsets may also differ from one another with respect to reactivity and tolerance to self-Ags. Transitional B cells, particularly the T-1 subset, are believed to be highly tolerance susceptible (13, 14) . B-1 and MZ B cells are believed to retain low-affinity self-reactivity and perhaps require it for survival or differentiation (15) (16) (17) (18) (19) (20) (21) , whereas the evidence for such self-ligand-dependent positive selection among normal follicular cells is speculative or indirect (22) (23) (24) . In contrast, in some autoantibody transgenic models, self-reactive MZ B cells are eliminated by levels of autoantigen that render follicular B cells anergic but viable (25) ; other studies also suggest that MZ B cells are particularly sensitive to BCR-mediated apoptosis (26, 27) . B-1 cells seem to require continual, weak BCR signaling for development and persistence (10, 16, 28) . Indeed, the repertoire of BCRs that promote B-1 development is largely nonoverlapping with the repertoire that promotes follicular B cell development (29, 30) , probably because higher levels of BCR signaling are required for differentiation to B-1 vs follicular B cell phenotype (10, 16, 19, 28, (31) (32) (33) . It would be desirable to develop an experimental system in which tolerance in different B lymphocyte subsets could be evaluated using a ligand common to all of these diverse subtypes.
We recently introduced a new model of B cell tolerance involving custom-designed superantigens, called macroself Ags, that allows analysis of tolerance in a normal, polyclonal immune system (34) . In an initial study, a ubiquitously expressed, membrane-tethered, Igreactive macroself Ag induced profound self-tolerance by receptor editing. In this study, results are presented from a transgenic mouse line expressing very low levels of the same macroself Ag in which tolerance by peripheral deletion of B-2 and MZ B cells predominates, whereas B-1 cells are spared. The results provide new insight into the relative tolerance sensitivity of B cell subsets.
Resources facility according to Institutional Animal Care and Use Committee guidelines. C57BL6/J (B6) and B6.CD45.1 mice were obtained from The Jackson Laboratory.
Generation of -macroself transgenes and production of transgenic mice
The construction of the -macroself coding sequences, the pUli transgene, and methods used to generate pUIi transgenic mice have been described previously (34) . Mice analyzed were backcrossed at least four times to the B6.CD45.1 background.
Bone marrow chimeras
Recipient mice were -macroself transgenics or littermate controls; all carried the CD45.1 allele. Recipients received 950 rad of ␥ radiation on the day of transfer. Bone marrow donors were all of the CD45.2 allotype. Bone marrow cell suspensions were depleted of T cells by treatment with biotinylated anti-Thy1.2 Abs and anti-biotin magnetic beads (Miltenyi Biotec) according to the suggested protocol. Five million cells were transferred i.v. per recipient. After 6 wk, recipients were killed, and their lymphoid tissues were analyzed by flow cytometry. Only chimeras in which Ն98% of cells in bone marrow and spleen were donor derived were included in the analysis.
Flow cytometric analysis
Nucleated cell suspensions were prepared from bone marrow, spleen, mesenteric lymph nodes, and peritoneal cavity. Erythrocytes were eliminated from the spleen and bone marrow preparations by ammonium chloride treatment. Cells were stained in a solution of PBS, 1% BSA, and 0.2% azide containing appropriately diluted combinations of the following mAbs: biotin-coupled mouse anti-rat IgG1 developed with streptavidin-PE; PE and biotin rat anti-mouse Ig (187.1); biotin anti-Ig 1-3 , followed by PE-or allophycocyanin-streptavidin; PerCP-coupled or FITC-coupled anti-CD45R/B220 (RA3-6B2); Cy5-coupled anti-IgM (331.12); PE-coupled anti-CD45.1 (eBioscience); FITC-coupled anti-CD45.2 (eBioscience); FITC-coupled anti-CD21; PE-coupled anti-CD23; PE-coupled anti-CD24 (HSA); and FITC-coupled anti-CD5. Abs were purchased from BD Pharmingen unless specified. Biotin-coupled Abs were revealed with streptavidin-PE (BD Pharmingen). Cells were gated on the basis of forward and side scatter criteria to avoid contamination by dead cells or debris. Stained cells were analyzed on a FACSCaliber flow cytometer (BD Biosciences) using the FlowJo analysis program.
RNA analysis of transgene expression
Total RNA was extracted from the spleen, bone marrow, liver, kidney, muscles, lungs, and heart of nontransgenic littermate, pUli low transgenic, and pUli high transgenic mice with TRIzol (Invitrogen). cDNA was generated from total RNA using the SuperScript III First-Strand Synthesis System for RT-PCR kit according to the manufacturer's instructions (Invitrogen). For -macroself Ag expression, PCRs were done in a final volume of 50 l using the Platinum Taq polymerase system (Invitrogen) with the following primers: 5Ј-gtcatgaaccatcactttacaatctggg-3Ј; 5Ј-cagcggag gcggtgggtcggg-3Ј. Samples were amplified for 25 or 30 cycles: 1 min at 94°C, 1 min at 60°C, 1 min at 72°C. PCR products were electrophoresed in 1% agarose gel containing 5 g/ml ethidium bromide. PCR products were visualized on gel exposure to UV light using an AlphaImage apparatus (Alpha Innotech). A 960-bp PCR product was amplified from tissues expressing the -macroself Ag.
Ig gene rearrangement PCR assays
Nontransgenic littermate and pUli low spleen B cells were first stained for B220 and Ig. Ig-positive cells were sorted in 1ϫ PBS, 1 mM EDTA, 25 mM HEPES (pH 7.0), and 1% FCS using a FACS Vantage cell sorter (BD Biosciences). Ig spleen B cells from pUli high transgenic mice were isolated using the anti-B220 magnetic bead cell purification system (Miltenyi Biotec). The purity of these preparations was Ͼ95% in all cases. Genomic DNA was extracted with the QIAamp DNA Mini kit (Qiagen) according to the manufacturer's protocol. PCRs were done in a final volume of 50 l containing 100, 25, or 12 ng of B cell genomic DNA. V1-to-J1 excision product and V1-to-J1 and RS-to-IRS DNA rearrangements were detected and using the primers and the PCR conditions described previously (35) (36) (37) . PCR products were electrophoresed in 1.5% agarose gels, blotted on nylon membranes, and probed with DNA probes as described previously (35) (36) (37) .
BrdU labeling
pUli low transgenic and nontransgenic littermate mice were given daily injections of 1 mg of BrdU in the peritoneum for 3 to 7 days. For BrdU uptake studies, surface-stained spleen and peritoneum cells were fixed, permeabilized, DNase treated, and stained with FITC anti-BrdU Ab using a BrdU Flow kit (BD Biosciences) according to the manufacturer's instructions.
Serum Ig determinations
Polyvinylchloride plastic microplates (Falcon) were coated with rat mAbs specific for IgG2a ϩ 2b, IgA, IgG1 (BD Pharmingen), and IgM (331.12). After washing and blocking, sera (diluted in PBS supplemented with 1% BSA) were incubated 3 h at room temperature. Bound Ig was detected using biotinylated anti-mouse Ig 1-3 , anti-mouse Ig, or HRP-conjugated anti-mouse Ig (187.1). Biotinylated Abs were revealed using streptavidin-peroxidase (Sigma-Aldrich), followed by the addition of the chromogenic substrate TMB (3,3Ј-tetramethylbenzidine; Pierce). The reaction was stopped with the addition of a 2 M H 2 SO 4 solution. Absorbance (450 nm) was measured on a Spectra MAX250 
Results

pUIi
low transgenic mice B cell tolerance was studied in transgenic mice expressing the pUli gene construct, which encodes a membrane-tethered, Ig-reactive single-chain Ab under the control of the ubiquitin C promoter (Fig. 1A) . A novel, low-expressing -macroself Ag transgenic line (pUli low ) was generated and compared with the previously described pUli transgenic line 2 (34) . For the sake of simplicity, we will refer in this report to the pUli line 2 strain as pUIi high , although it expresses a level of -macroself Ag that is intermediate among our panel of transgenics. Ig ϩ cells in pUIi high mice were shown previously to undergo central B cell tolerance by developmental arrest in the bone marrow and extensive receptor editing (34) . Similar results were obtained with 11 of 12 pUli transgenic lines. As we show below, the pUli low mouse line described here, which appears to have the lowest transgene expression levels, had a distinct B cell tolerance phenotype. The pUli low mouse expresses very low levels of the -macroself Ag on the bone marrow and spleen cells compared with pUIi high mice (Fig. 1B) . The pUlik low mouse expresses low levels of soluble -macroself Ag in the serum (Ͻ50 ng/ml), as determined by ELISA (data not shown).
RT-PCR analysis revealed that transgene expression could be detected in most tissues of pUli low mice (Fig. 1C) , but, in contrast to pUIi high tissues, at lower numbers of amplification cycles, many tissues scored negative. This expression difference provided an opportunity to study how low levels of self-Ag influence tolerance induction. ϩ cells in the indicated tissues of -macroself Ag transgenic and nontransgenic mice given with overall viable cell numbers (see Fig. 2 ). In all experiments, bone marrow samples were analyzed using a lymphocyte gate to exclude most myeloid lineage cells. BM, Bone marrow; LN, lymph node; Non-Tg, nontransgenic. (Figs. 2B and 3) , this corresponded to only a modest numerical increase in the spleen and lymph nodes of 2-fold and 20%, respectively. In bone marrow of pUli low mice, numbers of newly formed B220 int / ϩ cells were also modestly increased relative to nontransgenic littermates (Fig. 4, A and C) , but this difference was not statistically significant. In contrast, and as expected (34) , the pUIi high transgenic line had virtually no Ig ϩ cells in the periphery, a 7-fold increase in ϩ cells in the spleen and lymph nodes, and a 300 -400% increase in newly formed ϩ cells (Figs. 3 and 4C) . A second line of evidence came from PCR quantitation of DNA rearrangements associated with -to-editing, including RS recombination to the locus J-C intronic sites and V-to-J excision products (Fig. 4, B ϩ cells, reduced levels of B220 and CD21, and elevated levels of HSA (Fig. 5B) . AA4.1 ϩ cells (transitional type 1 cells) were proportionately more frequent than in controls (Fig. 5C) (Fig. 5D , bottom panels, and data not shown). Although the fraction of transitional B cells is preserved in the pUli low transgenic mice, MZ B cells were increased in frequency relative to other B cell subsets, but not in overall numbers (Fig. 5E ). We were unable to detect ϩ cells of a B-1 phenotype in the spleens of pUli low mice (data not shown). The results suggest that in the periphery of pUli low transgenic mice, ϩ B cells undergo developmental arrest or fail to survive long enough to differentiate normally.
Persistence of Ig ϩ B-1 phenotype B cells in peritonea ofmacroself transgenic mice
Tolerance in the B-1 compartment was assessed simply by evaluating the sIgL phenotype of peritoneal B cells. Interestingly, pUli low mice had significant numbers of sIg ϩ cells in the peritoneal cavity, whereas pUIi high transgenic mice lacked all peripheral sIg ϩ cells (Fig. 6, A and C) . To determine the B cell subset type of sIg ϩ in the peritonea of pUli low mice, gated Ig ϩ cells were evaluated for expression of the B-1 cell markers CD43, CD5, and Mac-1/CD11b (Fig. 6B) 
BrdU uptake studies
To assess the turnover of Ig B cells in the spleen and peritoneal cavity, mice were given BrdU for 3 or 7 days, and the uptake into DNA was determined using a flow cytometry assay. As shown in Fig. 7, first 
Use of macroself transgenic mice as recipients in radiation chimeras
To assess -macroself Ag-induced tolerance in a context in which B cells themselves cannot express macroself Ag, a bone marrow radiation chimera approach was adopted (Fig. 8) . Wild-type bone marrow was transferred into lethally irradiated pUli low , pUli high , and nontransgenic mice and recipients analyzed 6 wk after reconstitution. As shown in Fig. 8, pUli low recipients had reduced sIg ϩ B cell numbers in the spleen and lymph nodes but not in bone marrow, with a modest increase in ϩ B cells. In contrast, the peripheral lymphoid organs of pUli high recipients had few ϩ B cells and many ϩ B cells (Fig. 8, A and C) . Costaining for sIg and IgM gave an independent measure of Ag receptor levels independent of L chain usage (Fig. 8B) mice, possibly because of the presence of fewer superantigen-expressing cells. The results further suggested that central tolerance and receptor editing predominate in pUli high recipients, whereas in pUli low recipients, a peripheral, rather than central, B cell tolerance phenotype is seen.
Serum Ab levels in -macroself transgenic mice
Levels of serum Ig and Ig in pUli low transgenic mice were assessed to determine whether tolerance suppressed spontaneous Ig Ab secretion and to determine the Ig H chain isotype profile of the Abs (Table I) . A substantial but incomplete reduction in serum IgM, levels was found in pUli low transgenic mice, whereas levels of IgA, and IgG, were reduced nearly to background levels. In contrast, essentially no Ig Ig of any kind was found in pUli high transgenic sera (34) . A reciprocal increase in serum Ig levels was found in the pUli low transgenic mice (Table II) . We conclude that in pUli low transgenic mice, partial peripheral B cell tolerance occurs in mouse Ig ϩ cells but that considerable numbers of Ig ϩ immature B cells and B-1 cells are retained, leading to the spontaneous formation of significant levels of serum IgM,.
Discussion
A novel model system to study peripheral B cell tolerance
We describe here a novel transgenic mouse line carrying Igreactive macroself Ag that induces peripheral B cell tolerance in a polyclonal immune system. Tolerance in pUli low mice results in a striking reduction in ϩ cells of MZ and follicular phenotype, a net decrease in B cells, and an increased rate of ϩ B cell turnover. These features are all consistent with toleranceinduced peripheral deletion. Although in pUli low mice ϩ B cells are somewhat elevated in numbers, particularly in the spleen, we have uncovered little evidence of -macroself Aginduced receptor editing. In pUli low mice, a partial reduction in, but not elimination of, ϩ cells was also noted in the B-1 compartment of the peritoneal cavity. A previous study assessed transgenic lines expressing the same -macroself cellsurface protein at higher levels in the bone marrow, including pUli high mice, in which a central tolerance phenotype was seen, characterized by a near total absence of peripheral ϩ cells and extensive receptor editing (34) . Because the pUli low transgenic mice described here carry the same transgene and encode exactly the same protein product as the pUli high mice, the altered phenotype described here is solely explained by the level of transgene expression. Furthermore, because the -macroself ligand reacts identically with the Ag receptors of all -expressing B cell subsets, without regard to fine specificity, it provides a relatively unbiased way to compare tolerance thresholds of different peripheral B cell subsets within the same animal.
The phenotype of the pUli low mice, although unique among the panel of transgenics carrying the pUli transgene, was similar to that found in a second -macroself transgenic line carrying a modified transgene driven by the MHC class I K b promoter and lacking the leader intron (data not shown). Therefore, it is unlikely that genetic alterations to the transgene explain the phenotype of pUli low mice. Rather, we suspect that in pUli low mice, and in the second line with a similar phenotype, the low level of macroself Ag in the bone marrow fails to induce significant receptor editing, leading to the migration of Ig ϩ cells to the periphery, where the prolonged duration of low-level signaling promotes peripheral tolerance. It is difficult to say from the data available whether the lack of ϩ B-2 and MZ B cells in pUli low mice is dependent on the stage of development of the cells at the time of significant Ag encounter or the microenvironment in which Ag is encountered. Previous studies have provided evidence supporting both of these possibilities (4, 5, 35, 36, 38 -40) . In any case, the signaling induced by low-level -macroself ligand in both mice is such that Ig ϩ B-1 cells are spared, whereas other B cell subsets are counterselected.
Differential effects on B cell subsets
The relationship between peripheral B cell subset type and sensitivity to B cell tolerance or autoantibody formation is poorly understood. The present studies are significant because they are the first to directly assess the sensitivity of phenotypically and functionally distinct B cell compartments to the same Ag. The pUli low transgenic mice had striking losses of Ig ϩ cells in follicular and MZ B cell compartments, whereas clonal elimination was limited in the B-1 compartment. Remarkably, ϩ cells constituted a major fraction (approximately one-third) of the peritoneal B-1 cell compartment of pUli low mice, whereas ϩ B-2 phenotype cells were absent in the same cell preparations. Peritoneal B-1 cells are known to be tolerance susceptible after acute administration of ligands (41) but are likely also dependent on self-Ag ligands for survival, development, or expansion (16, 21, 28, 42, 43) . It may be that the relative paucity of Ig ϩ follicular and MZ B cells in pUli low transgenic mice is the result of the elimination or developmental block of their precursors at the immature B cell stage. The fetal precursors of B-1a cells are distinct from those of follicular and MZ B cells, which are bone marrow derived. Thus, it is possible that the tolerance thresholds of these precursors differ, or that they encounter different levels of macroself Ag. However, it is also possible that maturing MZ and follicular B cells have a lower threshold for tolerance induction than do B-1 lineage cells. In any case, mature B-1 cells appear to persist in an antigenic environment in which MZ and B-2 cells are counterselected.
It is unclear whether the signal strength of the BCR/-macroself Ag drives the differentiation of some cells to the B-1 phenotype in pUli low mice or whether B-1 development is independently regulated by the Ag receptor combining sites. It has been proposed based on work with endoplasmic reticulumtargeted hen egg lysozyme transgenic mice that Ags that promote B-1 development may preferentially be intracellular selfAgs (21) . According to this model, intracellular Ags are stimulatory because exposure to them is limited to situations in which cell death occurs, a setting that would deliver TLR costimulation promoting B-1 development. However, in that study, low levels of hen egg lysozyme were apparent on the cell surface. Furthermore, Hayakawa et al. (28) found that one class of B-1 cells sees, and is selected by, the familiar Thy-1 molecule, a cell surface Ag. Although difficult to rule out, because all Ags must be expressed intracellularly at some level, we have no evidence that the -macroself Ag used here, with its Ig leader peptide, MHC class I-derived transmembrane and cytoplasmic tail, is selectively retained inside cells. A more straightforward interpretation for our results would be that the low levels of accessible, membrane-displayed -macroself Ag present in pUli low mice fail to achieve a critical threshold of signaling needed for tolerance in the B-1 compartment, while failing to disrupt or actively induce B-1-positive selection.
It is interesting that the ϩ cells in the peritonea of pUli low mice solely had the phenotype of fetal derived B-1a B cells and lacked the bone marrow-derived B-1b or B-2 phenotypes. Our finding of low BrdU uptake in these cells suggests that ϩ cells of pUli low mice are long-lived and therefore resistant to clonal elimination by the macroself Ag, whereas bone marrow-derived B-1b cells fail to develop in the presence of the identical self-ligands. This result is reminiscent of those of Hayakawa et al. (28) in the anti-Thy B1 model. In addition, in that study, Ab reactive with self-Ag (Thy1, CD90) was present and actively induced by autoantigen. Similar to the -macroself Ag expression profile in the pUlik low transgenic mice, the Thy1 autoantigen is also broadly distributed in mouse tissues (44) . However, because of the normally high levels of IgM, in serum, it is unclear whether the IgM, Ab in pUli low mice is actively induced by -macroself Ag or rather is partly counterselected by it. Additional experiments will be needed to address this issue.
The present study underscores the observation that autoreactive B cells failing to see Ag in the bone marrow may be tolerized in the periphery by deletion or an anergy-associated reduction in lifespan (5, 6, 45-48) . The finding that MZ B cells apparently are eliminated in this model is consistent with studies with experimental tolerogens that this compartment may be particularly tolerance sensitive (25) (26) (27) but is inconsistent with another body of data suggesting that the MZ compartment is enriched in cells with selfreactive specificities (18, 42, 49) . One possible explanation for this discrepancy is that, in contrast to the macroself Ag used here, certain self-Ags may promote B cell survival by delivering associated Tlr ligands, such as nucleic acids (50, 51). 
